Nicolet Advisory Services’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$635K Sell
3,770
-1,408
-27% -$221K 0.04% 199
2025
Q3
$756K Buy
5,178
+498
+11% +$60.5K 0.06% 167
2025
Q2
$556K Buy
4,680
+1,073
+30% +$137K 0.05% 202
2025
Q1
$415K Buy
3,607
+345
+11% +$53.1K 0.04% 221
2024
Q4
$505K Buy
3,262
+8
+0.2% +$1.15K 0.05% 197
2024
Q3
$452K Buy
3,254
+201
+7% +$28.8K 0.04% 218
2024
Q2
$369K Buy
3,053
+804
+36% +$126K 0.04% 250
2024
Q1
$409K Buy
2,249
+802
+55% +$153K 0.04% 217
2023
Q4
$248K Buy
+1,447
New +$225K 0.03% 281

Other funds holding RGEN

Nicolet Advisory Services's RGEN Position: Q4 2025 in Review

Nicolet Advisory Services reduced its Repligen (RGEN) stake by 27% in Q4 2025, selling an estimated $221K and leaving 3,770 shares worth $635K. The position accounts for 0.04% of the portfolio, ranked #199.

Nicolet Advisory Services first reported a position in RGEN in Q4 2023 and has held it in 9 quarters since. The position peaked at $756K in Q3 2025. 474 funds tracked by Wall St. Rank hold RGEN as of Q4 2025.

  • Nicolet Advisory Services held 3,770 shares of Repligen worth $635K as of Q4 2025.
  • Nicolet Advisory Services sold 1,408 Repligen shares in Q4 2025, an estimated $221K.
  • Repligen made up 0.04% of Nicolet Advisory Services's portfolio in Q4 2025, its #199 holding.
  • Nicolet Advisory Services first reported a position in Repligen in Q4 2023 and has held it in 9 quarters since.
  • Nicolet Advisory Services's Repligen position peaked at $756K in Q3 2025.
  • 474 funds tracked by Wall St. Rank held Repligen as of Q4 2025.

Based on Nicolet Advisory Services's 13F filing for Q4 2025, filed 13 Feb 2026.